CTXR
Citius Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$15.46M
P/E Ratio
—
EPS
$-2.46
Beta
1.38
52W High
$2.48
52W Low
$0.63
50-Day MA
$0.80
200-Day MA
$1.10
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.42
PEG Ratio
0.00
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. The company is headquartered in Cranford, New Jersey.
Fundamentals
| Revenue (TTM) | $3.94M |
| Gross Profit (TTM) | $3.15M |
| EBITDA | $-36.36M |
| Operating Margin | -214.10% |
| Return on Equity | -47.80% |
| Return on Assets | -17.70% |
| Revenue/Share (TTM) | $0.27 |
| Book Value | $3.57 |
| Price-to-Book | 0.19 |
| Price-to-Sales (TTM) | 3.92 |
| EV/Revenue | 2.426 |
| EV/EBITDA | -2.74 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $22.38M |
| Float | $21.88M |
| % Insiders | 2.20% |
| % Institutions | 7.69% |
Historical Volatility
HV 10-Day
125.92%
HV 20-Day
144.52%
HV 30-Day
123.06%
HV 60-Day
117.74%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($6.00 target)
1
Buy1
HoldData last updated: 4/28/2026